Arrowhead Pharmaceuticals Inc. (ARWR)
Market Closed
16 Oct, 08:00 PM
$
55. 90
-2.6
-4.4444%
$
8.22B Market Cap
- P/E Ratio
- Div Yield
1.77M Volume
-1.55 Eps
$ 58.5
Previous Close 
Want to track ARWR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Arrowhead Pharmaceuticals Inc. (ARWR) Statistics
Valuation metrics
Market Cap 8.22B
Enterprise value 8.71B
Trailing P/E (ttm) -24.96
Forward P/E -17.29
PEG ratio 0
Price/Sales (ttm) 11.79
Price/Book (mrq) 17.22
Enterprise Value/Revenue 13
Enterprise Value/EBITDA -65.13
Overview
Shares outstanding 140.57M
Float 122.81M
Shares short 12.94M
% Held by insiders 0.04%
% Held by institutions 0.89%
Average volume (10 days) 2.22M
Average volume (90 days) 1.89M
Price summary
52-Week low 36.57
52-Week high 95.49
Beta 1.29
50-Day moving average 70.26
200-Day moving average 75.92
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -0.12
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 17 Nov 2011
Financials
Fiscal year
Fiscal year ends 30 Sep 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -0.48%
Operating margin -0.34%
Operational effectiveness
Return on assets -0.15%
Return on equity -0.61%
Income Statement
Revenue (ttm) 622.01M
Revenue per share (ttm) 4.67
Quarterly revenue growth (yoy) -0.86%
Gross profit (ttm) 622.01M
EBITDA 164.82M
Net income to common (ttm) -300.91M
Diluted EPS (ttm) -2.23
Quarterly earnings growth (yoy) -0.86%
Balance Sheet
Total cash (mrq) 1.78B
Total cash per share (mrq) 11.17
Total debt (mrq) 1.38B
Total Debt/Equity (mrq) 1.86
Current ratio (mrq) 5.9%
Book value per share (mrq) 3.25
Cash Flow
Cash flow statement -36.31M
Levered free cash flow (LFCF) -46.12M
2026 © Marketlog. All Rights Reserved.
